"use strict";(self.webpackChunkaurorahelp=self.webpackChunkaurorahelp||[]).push([[3134],{3905:(e,i,t)=>{t.d(i,{Zo:()=>p,kt:()=>g});var a=t(7294);function n(e,i,t){return i in e?Object.defineProperty(e,i,{value:t,enumerable:!0,configurable:!0,writable:!0}):e[i]=t,e}function r(e,i){var t=Object.keys(e);if(Object.getOwnPropertySymbols){var a=Object.getOwnPropertySymbols(e);i&&(a=a.filter((function(i){return Object.getOwnPropertyDescriptor(e,i).enumerable}))),t.push.apply(t,a)}return t}function l(e){for(var i=1;i<arguments.length;i++){var t=null!=arguments[i]?arguments[i]:{};i%2?r(Object(t),!0).forEach((function(i){n(e,i,t[i])})):Object.getOwnPropertyDescriptors?Object.defineProperties(e,Object.getOwnPropertyDescriptors(t)):r(Object(t)).forEach((function(i){Object.defineProperty(e,i,Object.getOwnPropertyDescriptor(t,i))}))}return e}function c(e,i){if(null==e)return{};var t,a,n=function(e,i){if(null==e)return{};var t,a,n={},r=Object.keys(e);for(a=0;a<r.length;a++)t=r[a],i.indexOf(t)>=0||(n[t]=e[t]);return n}(e,i);if(Object.getOwnPropertySymbols){var r=Object.getOwnPropertySymbols(e);for(a=0;a<r.length;a++)t=r[a],i.indexOf(t)>=0||Object.prototype.propertyIsEnumerable.call(e,t)&&(n[t]=e[t])}return n}var s=a.createContext({}),o=function(e){var i=a.useContext(s),t=i;return e&&(t="function"==typeof e?e(i):l(l({},i),e)),t},p=function(e){var i=o(e.components);return a.createElement(s.Provider,{value:i},e.children)},h="mdxType",m={inlineCode:"code",wrapper:function(e){var i=e.children;return a.createElement(a.Fragment,{},i)}},d=a.forwardRef((function(e,i){var t=e.components,n=e.mdxType,r=e.originalType,s=e.parentName,p=c(e,["components","mdxType","originalType","parentName"]),h=o(t),d=n,g=h["".concat(s,".").concat(d)]||h[d]||m[d]||r;return t?a.createElement(g,l(l({ref:i},p),{},{components:t})):a.createElement(g,l({ref:i},p))}));function g(e,i){var t=arguments,n=i&&i.mdxType;if("string"==typeof e||n){var r=t.length,l=new Array(r);l[0]=d;var c={};for(var s in i)hasOwnProperty.call(i,s)&&(c[s]=i[s]);c.originalType=e,c[h]="string"==typeof e?e:n,l[1]=c;for(var o=2;o<r;o++)l[o]=t[o];return a.createElement.apply(null,l)}return a.createElement.apply(null,t)}d.displayName="MDXCreateElement"},6813:(e,i,t)=>{t.r(i),t.d(i,{assets:()=>s,contentTitle:()=>l,default:()=>h,frontMatter:()=>r,metadata:()=>c,toc:()=>o});var a=t(7462),n=(t(7294),t(3905));const r={authors:"Hunter",tags:["AuroraPrime","Create","GenAI"]},l="The Latest News on GenAI in Clinical Trials",c={permalink:"/blog/2024/09/27/ The Latest News on GenAI in Clinical Trials",source:"@site/blog/2024-09-27 The Latest News on GenAI in Clinical Trials.md",title:"The Latest News on GenAI in Clinical Trials",description:"Leveraging the power of generative AI to streamline clinical trials (09/06/2024)",date:"2024-09-27T00:00:00.000Z",formattedDate:"September 27, 2024",tags:[{label:"AuroraPrime",permalink:"/blog/tags/aurora-prime"},{label:"Create",permalink:"/blog/tags/create"},{label:"GenAI",permalink:"/blog/tags/gen-ai"}],readingTime:2.355,hasTruncateMarker:!1,authors:[{name:"Hunter Shen",title:"generative AI evangelist",imageURL:"https://video.myaurora.cn/adhoc/huntershen.jpeg",key:"Hunter"}],frontMatter:{authors:"Hunter",tags:["AuroraPrime","Create","GenAI"]},prevItem:{title:"How to Master the Art of Prompt Writing for AI Models in Medical Writing",permalink:"/blog/2024/09/28/ How to Master the Art of Prompt Writing for AI Models in Medical Writing"},nextItem:{title:"Generative AI and Its Transformative Role in Medical Writing and Clinical Trials",permalink:"/blog/2024/09/26/ Generative AI and Its Transformative Role in Medical Writing and Clinical Trials"}},s={authorsImageUrls:[void 0]},o=[{value:"Leveraging the power of generative AI to streamline clinical trials (09/06/2024)",id:"leveraging-the-power-of-generative-ai-to-streamline-clinical-trials-09062024",level:2},{value:"Reshaping data science using generative AI (08/02/2024)",id:"reshaping-data-science-using-generative-ai-08022024",level:2},{value:"Study shows generative AI can speed up clinical trial enrollment for pennies per patient (06/21/2024)",id:"study-shows-generative-ai-can-speed-up-clinical-trial-enrollment-for-pennies-per-patient-06212024",level:2},{value:"Generative AI in clinical trials: Practical use cases and common concerns (06/25/2024)",id:"generative-ai-in-clinical-trials-practical-use-cases-and-common-concerns-06252024",level:2},{value:"Unleashing The Power Of Generative AI In Clinical Trials (05/23/2024)",id:"unleashing-the-power-of-generative-ai-in-clinical-trials-05232024",level:2},{value:"Triomics raises $15M Series A to automate cancer clinical trials matching (05/09/2024)",id:"triomics-raises-15m-series-a-to-automate-cancer-clinical-trials-matching-05092024",level:2},{value:"How NIH\u2019s National Library of Medicine is testing AI to match patients to clinical trials (04/15/2024)",id:"how-nihs-national-library-of-medicine-is-testing-ai-to-match-patients-to-clinical-trials-04152024",level:2},{value:"Optimizing Generative AI In Clinical Operations Through Focus Restraint And Maximized Validation (04/18/2024)",id:"optimizing-generative-ai-in-clinical-operations-through-focus-restraint-and-maximized-validation-04182024",level:2}],p={toc:o};function h(e){let{components:i,...r}=e;return(0,n.kt)("wrapper",(0,a.Z)({},p,r,{components:i,mdxType:"MDXLayout"}),(0,n.kt)("p",null,(0,n.kt)("img",{src:t(3563).Z,width:"1184",height:"672"})),(0,n.kt)("h2",{id:"leveraging-the-power-of-generative-ai-to-streamline-clinical-trials-09062024"},(0,n.kt)("a",{parentName:"h2",href:"https://www.sia-partners.com/en/insights/publications/leveraging-power-generative-ai-streamline-clinical-trials"},"Leveraging the power of generative AI to streamline clinical trials")," (09/06/2024)"),(0,n.kt)("p",null,"Generative AI is revolutionizing clinical trials by improving efficiency and reducing costs. This article explores how AI technologies are being utilized to streamline various aspects of clinical trials, from patient recruitment to data analysis. The integration of AI in clinical research promises to accelerate the drug development process and enhance the accuracy of trial outcomes."),(0,n.kt)("h2",{id:"reshaping-data-science-using-generative-ai-08022024"},(0,n.kt)("a",{parentName:"h2",href:"https://www.astrazeneca.com/what-science-can-do/topics/data-science-ai/generative-ai-drug-discovery-development.html"},"Reshaping data science using generative AI")," (08/02/2024)"),(0,n.kt)("p",null,"AstraZeneca discusses how generative AI is reshaping data science in drug discovery and development. The technology aids in identifying novel drug candidates and optimizing clinical trial processes. By leveraging AI, AstraZeneca aims to accelerate the development of new therapies and improve patient outcomes."),(0,n.kt)("h2",{id:"study-shows-generative-ai-can-speed-up-clinical-trial-enrollment-for-pennies-per-patient-06212024"},(0,n.kt)("a",{parentName:"h2",href:"https://www.fiercebiotech.com/medtech/study-shows-generative-ai-can-speed-clinical-trial-enrollment-pennies-patient"},"Study shows generative AI can speed up clinical trial enrollment for pennies per patient")," (06/21/2024)"),(0,n.kt)("p",null,"A study reveals that generative AI can significantly expedite clinical trial enrollment at a minimal cost per patient. The technology enhances the recruitment process by identifying suitable candidates more efficiently, thereby reducing the time and expenses associated with patient enrollment in clinical trials."),(0,n.kt)("h2",{id:"generative-ai-in-clinical-trials-practical-use-cases-and-common-concerns-06252024"},(0,n.kt)("a",{parentName:"h2",href:"https://pharmaphorum.com/rd/generative-ai-clinical-trials-practical-use-cases-and-common-concerns"},"Generative AI in clinical trials: Practical use cases and common concerns")," (06/25/2024)"),(0,n.kt)("p",null,"This article explores practical use cases of generative AI in clinical trials and addresses common concerns. It highlights how AI is used to improve trial design, patient recruitment, and data analysis. The discussion also covers potential challenges and ethical considerations in implementing AI technologies in clinical research."),(0,n.kt)("h2",{id:"unleashing-the-power-of-generative-ai-in-clinical-trials-05232024"},(0,n.kt)("a",{parentName:"h2",href:"https://www.contractpharma.com/contents/view_experts-opinion/2024-05-23/unleashing-the-power-of-generative-ai-in-clinical-trials/"},"Unleashing The Power Of Generative AI In Clinical Trials")," (05/23/2024)"),(0,n.kt)("p",null,"Generative AI is unleashing new potentials in clinical trials by enhancing various processes such as patient recruitment, trial design, and data analysis. This article discusses how AI-driven approaches can lead to more efficient and cost-effective clinical trials, ultimately accelerating the development of new therapies."),(0,n.kt)("h2",{id:"triomics-raises-15m-series-a-to-automate-cancer-clinical-trials-matching-05092024"},(0,n.kt)("a",{parentName:"h2",href:"https://techcrunch.com/2024/05/09/triomics-raises-15m-for-cancer-clinical-trials-a/"},"Triomics raises $15M Series A to automate cancer clinical trials matching")," (05/09/2024)"),(0,n.kt)("p",null,"Triomics has secured $15 million in Series A funding to automate the matching process for cancer clinical trials. The company leverages generative AI to streamline patient recruitment and improve trial efficiency. This funding will support the expansion of their AI-driven platform and enhance their capabilities in clinical research."),(0,n.kt)("h2",{id:"how-nihs-national-library-of-medicine-is-testing-ai-to-match-patients-to-clinical-trials-04152024"},(0,n.kt)("a",{parentName:"h2",href:"https://fedscoop.com/how-nihs-national-library-of-medicine-is-testing-ai-to-match-patients-to-clinical-trials/"},"How NIH\u2019s National Library of Medicine is testing AI to match patients to clinical trials")," (04/15/2024)"),(0,n.kt)("p",null,"The National Library of Medicine at NIH is testing AI technologies to match patients to clinical trials more effectively. This initiative aims to improve the accuracy and efficiency of patient recruitment, thereby accelerating the clinical trial process and enhancing the development of new treatments."),(0,n.kt)("h2",{id:"optimizing-generative-ai-in-clinical-operations-through-focus-restraint-and-maximized-validation-04182024"},(0,n.kt)("a",{parentName:"h2",href:"https://www.clinicalleader.com/doc/optimizing-generative-ai-in-clinical-operations-through-focus-restraint-and-maximized-validation-0001"},"Optimizing Generative AI In Clinical Operations Through Focus Restraint And Maximized Validation")," (04/18/2024)"),(0,n.kt)("p",null,"This article discusses strategies for optimizing the use of generative AI in clinical operations. It emphasizes the importance of focus, restraint, and validation to maximize the benefits of AI technologies. By implementing these strategies, clinical trials can achieve higher efficiency and accuracy."))}h.isMDXComponent=!0},3563:(e,i,t)=>{t.d(i,{Z:()=>a});const a=t.p+"assets/images/image_20240929150914-236e761db8d4da944c4fc55486242031.png"}}]);